GBL acquiring co-controlling stake in Rayner for €500m
Belgian-based, publicly traded investment holding company Groupe Bruxelles Lambert (GBL) has signed definitive agreements to acquire a 45% co-control stake in UK-based manufacturer of intraocular lenses and ophthalmic medical products Rayner. The transaction involves an equity investment of approximately €500m and will see GBL partnering with incumbent shareholder CVC Capital Partners and Rayner’s management team. Completion of the deal is…